Evidence map›Paper›PMID 40496870›Full record

ArticleFrontiers in immunology2025

Long COVID-19 autoantibodies and their potential effect on fertility.

Laura Talamini, Dennyson Leandro M Fonseca, Darja Kanduc, Olivier Chaloin, Cindy Verdot, Christian Galmiche, Arad Dotan, Igor Salerno Filgueiras, Maria Orietta Borghi, Pier Luigi Meroni and 15 more

Abstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Laura TalaminiCNRS UMR7242 Biotechnology and Cell Signalling, University of Strasbourg/Strasbourg Drug Discovery and Development Institute (IMS), Strasbourg, France.
Dennyson Leandro M FonsecaInterunit Postgraduate Program on Bioinformatics, Institute of Mathematics and Statistics (IME), University of São Paulo (USP), São Paulo, Brazil.
Darja KanducDepartment of Biosciences Biotechnologies and Biopharmaceutics, University of Bari, Bari, Italy.
Olivier ChaloinCNRS UPR3572 Immunology, Immunopathology and Therapeutic Chemistry, Institut de Biologie Moléculaire et Cellulaire (IBMC), Strasbourg, France.
Cindy VerdotCNRS UMR7242 Biotechnology and Cell Signalling, University of Strasbourg/Strasbourg Drug Discovery and Development Institute (IMS), Strasbourg, France.
Christian GalmicheUAR3415, Chronobiotron, Strasbourg, France.
Arad DotanZabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Ramat-Gan, Israel.
Igor Salerno FilgueirasDepartment of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Maria Orietta BorghiDepartment of Clinical Sciences and Community Health, University of Milan, Milano, Italy.
Pier Luigi MeroniExperimental Laboratory of Immunological and Rheumatologic Researches, Istituto Auxologico Italiano Istituto di Ricovero e Cura a Carattere Scientifico, Milano, Italy.
Natalia Y GavrilovaDepartment of Pathology and Laboratory of the Mosaic of Autoimmunity, Saint Petersburg State University, Saint-Petersburg, Russia.
Varvara A RyabkovaDepartment of Pathology and Laboratory of the Mosaic of Autoimmunity, Saint Petersburg State University, Saint-Petersburg, Russia.
Leonid P ChurilovDepartment of Pathology and Laboratory of the Mosaic of Autoimmunity, Saint Petersburg State University, Saint-Petersburg, Russia.
Gilad HalpertZabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Ramat-Gan, Israel.
Christian LenschDepartment of Pneumology, Allergology and Critical Care Medicine, ECLS Center Saar, Saarland University Hospital, Homburg/Saar, Germany.
Lorenz ThurnerJosé Carreras Center for Immuno and Gene Therapy and Department of Internal Medicine I, Saarland University, Homburg, Germany.
Siew-Wai FongASTAR Infectious Diseases Labs, Agency for Science, Technology and Research (ASTAR), Singapore, Singapore.
Lisa F P NgASTAR Infectious Diseases Labs, Agency for Science, Technology and Research (ASTAR), Singapore, Singapore.
Laurent RéniaASTAR Infectious Diseases Labs, Agency for Science, Technology and Research (ASTAR), Singapore, Singapore.
Barnaby E YoungLee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
David Chien LyeLee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
José Manuel LozanoUniversidad Nacional de Colombia-Sede Bogotá, Departamento de Farmacia, Mimetismo Molecular de los Agentes Infecciosos, Bogotá, DC, Colombia.
Otávio Cabral-MarquesInterunit Postgraduate Program on Bioinformatics, Institute of Mathematics and Statistics (IME), University of São Paulo (USP), São Paulo, Brazil.
Yehuda ShoenfeldZabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Ramat-Gan, Israel.
Sylviane MullerCNRS UMR7242 Biotechnology and Cell Signalling, University of Strasbourg/Strasbourg Drug Discovery and Development Institute (IMS), Strasbourg, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Impaired spermatogenesis has been reported in coronavirus disease 2019 (COVID-19) patients. However, the impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on male fertility remains unclear. The purpose of this multicenter study was to investigate the possible impact of SARS-CoV-2 infection on male fertility and determine the potential reasons leading to impaired male reproductive functions.

Indexed as

AutoantibodiesCOVID-19FertilityInfertility, MaleSARS-CoV-2AdultAnimalsAntibodies, ViralCross ReactionsFemaleHumansMaleMiceMiddle AgedSpike Glycoprotein, CoronavirusAntibodies, ViralAutoantibodiesSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2autoantibodiescoronavirus infectionmale reproductive systempeptide sequence identitypost-COVID-19 condition

Identifiers

PMID40496870
PMCPMC12149208

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.